King Black Acid, The Parson Red Heads, and LiquidLight at Doug Fir Lounge Vortex Music Magazine After 13 years, the folk family are set to release their fourth LP via Fluff & Gravy on June 9 but they'll celebrate their cosmic Americana a day early at Mississippi Studios with The Minus 5 and... King Black Acid: 'Big Gummo - It's Cool To Be In Love ... |
Read more from the original source:
King Black Acid, The Parson Red Heads, and LiquidLight at Doug Fir Lounge - Vortex Music Magazine
An artist's impression of the luminescent clouds, which should be visible along the mid-Atlantic coast after a NASA rocket launch.
NASA
Last Updated Jun 12, 2017 9:40 PM EDT
NASA is gearing up to launch a rocket that will create colorful, luminescent clouds that will be visible to skywatchers along the mid-Atlantic coastline.
The so-called sounding rocket was scheduled to launch Monday night a little after 9 p.m. EDT from NASA's Wallops Flight Facility on the Virginia shore. However, NASA decided at the last minute to postpone due to cloud cover at the observation sites and said it will try again to launch Tuesday night. Four previous launch attempts also had to be scrubbed for various reasons.
A few minutes after the rocket launch takes place, NASA will release ten soda-can-sized canisters containing blue-green and red vapor to form artificial clouds, the space agency explainedon its website.
These colorful clouds will allow NASA to visually track particle motions in space. The rocket launch will support deeper studies of the ionosphere -- a zone of the Earth's outer atmosphere -- andaurora, NASA said.
The luminescent clouds should make for a dramatic spectacle for East Coast residents in an area stretching from New York City and parts of Long Island south to the middle of North Carolina.
This map shows the projected visibility of the vapor tracers during the May 31 mission. The vapor tracers may be visible from New York to North Carolina and westward to Charlottesville, Virginia.
NASA
Not in the visibility zone?
You can watch live streaming coverage on the WallopsUstreamsite, and follow updates via its Facebook andTwitteraccounts.
2017 CBS Interactive Inc. All Rights Reserved.
Read more from the original source:
NASA launching colorful clouds over the East Coast -- here's how to watch - CBS News
New York Times | NASA's Newest Class of Astronauts Is Ready to Hit the Pool New York Times Last week, NASA announced its 22nd class of astronauts seven men and five women were chosen from more than 18,300 applicants, the most the space agency has ever received. They range in age from 29 to 42 and include an Army surgeon, ... ENG Alum Bob Hines Is NASA Astronaut Candidate NASA astronauts only make half as much as most commercial airline pilots Meet Jessica Watkins, The Only Black Woman In NASA's Newest Astronaut Class |
Excerpt from:
NASA's Newest Class of Astronauts Is Ready to Hit the Pool - New York Times
Setting up IKEA furniture may be difficult, but its not rocket science or is it? Thanks to a new collaboration between NASA and the Swedish furniture store, the two challenges may not be so differentafter all. IKEA is now looking into how a Mars habitat can become more like home, so that one day, if we do leave this planet, well be able to set up cheap, mass-produced furniture on new horizons, too.
In order to determine how best to create a Mars-ready home, an IKEA team is spending three days at MDRS Habitat in Utah, which the company describes as a confined spacecraft-like environment that simulates the experience of outer space. Its no joke NASAs own astronauts spend up to three years in this habitat in order to ready themselves for space travel.
Its a crazy, fun experience, IKEA creative leader Michael Nikolic said of the experience.Were basically completely isolated for three days to get a taste of what astronauts go through for three years. Its almost like that misery you feel when youre out camping.
But the hope is that it doesnt always have to be so miserable. Its unclear exactly what will come out of this collaboration, but IKEA says its curious to find out how this newfound space knowledge might be relevant to the urban life in mega cities, where small-space living, air and water pollution is the norm. So it may not even be that IKEA is making furniture for us to use on Mars rather, theyre attempting to use lessons gleaned from being an astronaut (or at least living like one) to improve the furniture that we have here on Earth.
I think that the essence of this collection will be about appreciating what we have on Earth: human beings, plants, clean water and air. But also diversity and a sense of belonging things that we take for granted on a daily basis, Nikolic added. After this journey, itll probably feel pretty awesome to come home to my own bed.
Read this article:
IKEA partners with NASA to make space a little more cozy - New York Post
Subscribe today for full access on your desktop, tablet, and mobile device.
312
Let friends in your social network know what you are reading about
NASA scrubs rocket launch from Wallops
Try Another
Audio CAPTCHA
Image CAPTCHA
Help
CancelSend
A link has been sent to your friend's email address.
A link has been posted to your Facebook feed.
DelmarvaNow Staff Report Published 7:36 p.m. ET June 12, 2017 | Updated 8 hours ago
A Black Brant IX sounding rocket takes off Tuesday, May 16, from Wallops Flight Facility.(Photo: Submitted image)
The launch ofa Terrier-Improved Malemute sounding rocket from Wallops Flight Facility, attempted several times before, canceled again on Monday, June 12.
NASA said the plan is to try to launch again Tuesday night shortly after 9.
FULL STORY: NASA to attempt colorful rocket launch tonight
Read or Share this story: http://www.delmarvanow.com/story/news/local/virginia/2017/06/12/watch-live-monday-nasa-launches-rocket-wallops/390084001/
11:56
0:34
0:40
1:34
2:17
2:37
1:29
1:19
2:20
1:29
1:21
0:50
0:31
0:38
0:46
2:55
1:18
3:08
1:09
1:34
The rest is here:
NASA cancels rocket launch because of cloud cover - Delmarva Daily Times
WASHINGTON, June 12, 2017 /PRNewswire-USNewswire/ --NASA will hold a media briefing at 11 a.m. EDT Monday, June 19, to announce the latest planet candidate results from the agency's exoplanet-hunting Kepler mission. The briefing, taking place during the Kepler Science Conference, will be held at NASA's Ames Research Center in California's Silicon Valley.
The event will stream live on NASA's website at:
The latest Kepler catalog of planet candidates was created using the most sophisticated analyses yet, yielding the most complete and reliable accounting of distant worlds to date. This survey will enable new lines of research in exoplanet study, which looks at planets outside our solar system.
The briefing participants are:
Media who are U.S. citizens and permanent residents may attend in person, and all media may participate by phone. To register for attendance or obtain dial-in information, contact Ames Public Affairs at 650-604-4789 or michele.johnson@nasa.gov by noon Friday, June 16. Media and the public may submit questions via Twitter using #AskKepler.
With its 2009 launch, NASA's Kepler space telescope became the first agency mission capable of finding Earth-sized planets in or near the habitable zone the range of distances from a star where liquid water could pool on the surface of a rocky planet. In the data collected during the four years of its principal mission, Kepler has detected thousands of planets and planet candidates, varying widely in size and orbital distances, helping us better understand our place in the universe.
For more information about the Kepler mission and to view the digital press kit, visit:
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/nasa-hosts-briefing-on-latest-results-of-exoplanet-hunting-mission-300472619.html
SOURCE NASA
Originally posted here:
NASA Hosts Briefing on Latest Results of Exoplanet-Hunting Mission - PR Newswire (press release)
(WFLA) Just when you thought NASA couldnt get any cooler, we discovered theyre giving away free posters.
You can now enjoy 14 different retro poster designs for free.
The poster series is titled Visions of the Future and features big moments in space history.
On the JPLwebsite, you can download one or all of these posters for free, and learn a little bit more about the moment in history each design represents.
NASA said the classic posters imaginative nature serves as a window into the future.
WHATS TRENDING ONLINE NOW
>>MOREFROM LILAS DIGITAL DOWNLOAD
Get Connected!
Stay with WFLA News Channel 8s Lila Gross for the latest trending news straight from social media.
WFLA.com provides commenting to allow for constructive discussion on the stories we cover. In order to comment here, you acknowledge you have read and agreed to our Terms of Service. Commenters who violate these terms, including use of vulgar language or racial slurs, will be banned. Please be respectful of the opinions of others and keep the conversation on topic and civil. If you see an inappropriate comment, please flag it for our moderators to review.
More here:
NASA gives away free posters to share big moments in history - WFLA
Written by AZoNanoJun 12 2017
Alberta Scientists have developed a new diagnostic that will allow men to avoid painful biopsies to check for aggressive prostate cancer. The test includes a unique nanotechnology system to make the diagnostic using just a single drop of blood, and is considerably more accurate than existing screening techniques.
University of Alberta prostate cancer researcher Dr. John Lewis, left, works with graduate student Srijan Raha. (CREDIT - University of Alberta)
The Extracellular Vesicle Fingerprint Predictive Score (EV-FPS) test applies machine learning to incorporate information from millions of cancer cell nanoparticles in the blood to identify the unique fingerprint of aggressive prostate cancer. The diagnostic, developed by members of the Alberta Prostate Cancer Research Initiative (APCaRI), was tested on a group of 377 Albertan men who were referred to their urologist with suspected prostate cancer. It was discovered that EV-FPS precisely identified men with aggressive prostate cancer 40% more accurately than the most common test used today - Prostate-Specific Antigen (PSA) blood test.
Higher sensitivity means that our test will miss fewer aggressive cancers. For this kind of test you want the sensitivity to be as high as possible because you don't want to miss a single cancer that should be treated.
John Lewis, the Alberta Cancer Foundation's Frank and Carla Sojonky Chair of Prostate Cancer Research, The University of Alberta
According to the team, existing tests such as the PSA and digital rectal exam (DRE) frequently lead to unnecessary biopsies. Lewis says over 50% of men who undergo a biopsy do not have prostate cancer, yet have to go through the pain and side effects of the procedure such as sepsis or infection. Below 20% of men who undergo a prostate biopsy are diagnosed with the aggressive form of prostate cancer that could highly benefit from treatment.
It is projected that effective implementation of the EV-FPS test could ultimately eliminate up to 600 thousand needless biopsies, 24 thousand hospitalizations and up to 50 % of avoidable treatments for prostate cancer annually in North America alone. Besides cost savings to the health care system, the Researchers say the diagnostic test will have a great impact on the health care experience and quality of life for men and their families.
Compared to elevated total PSA alone, the EV-FPS test can more accurately predict the result of prostate biopsy in previously unscreened men. This information can be used by clinicians to determine which men should be advised to undergo immediate prostate biopsy and which men should be advised to defer biopsy and continue prostate cancer screening.
Adrian Fairey, Urologist, The Northern Alberta Urology Centre and Member of APCaRI
The team will be launching the test into market through university spin-off company Nanostics Inc, which was founded by John Lewis, Desmond Pink, Catalina Vasquez and Robert Paproski.
See the article here:
New Nanotechnology-Based Blood Test for Predicting Prostate ... - AZoNano
The exciting landscape of modern life has been built with the aid of powerful computers. They have done dazzling things, from making the trains run on time to helping to build skyscrapers. Now, imagine a discontinuity in computing in which these capabilities are suddenly expanded and enhanced by orders of magnitude.
You wont have to imagine too much longer. It is in the process of happening. The fascinating thing is that this change is based on quantum science, which is completely counter-intuitive and not fully understood, even by those who are harnessing it.
Todays computers are binary, meaning that they are based on bits that represent either a 1 or a 0. As fast as they go, this is a basic, physical gating factor that limits how much work they can do in a given amount of time. The next wave of computers uses quantum bits called qubits that can simultaneously represent a 1 and a 0. This root of the mysteries that even scientists refer to as quantum weirdness allows the computers to do computations in parallel instead of sequentially. Not surprisingly, this greatly expands the ability of this class of computers.
The details of how quantum computers operate are more or less impossible to understand. A couple of related points are clear, however: Harnessing the power of quantum mechanics to create incredibly powerful machines is not a pipe dream: Companies such as IBM, Microsoft and Google, as well as startups and universities, dont sink billions of dollars in flights of fancy.
The second point is that the payoff is here, or at least quite near. The world of computing wont instantaneously change once quantum actions are proven. It is still a long road to being fully commercialized, bypassing classical approaches and, finally, living up to the most extravagant promise.
In late May, Microsoft and Purdue University announced research on quantum computing that focuses on one of the key challenges, which is the extraordinarily fragile nature of the qubits. Indeed, the subject of the research is a good example of the amazing complexity of the field and how far it has to go.
In quantum mechanics, the mere act of looking at the system makes it choose between the 1 and the 0 and exit the quantum state. The task of the Microsoft/Purdue research is to develop topological qubits that are stable enough to function in the real world.
In essence, according to Professor Michael Manfra, the university's Bill and Dee O'Brien Chair Professor of Physics and Astronomy, stability increases as the quantum properties are spread out.
The quantum variable that houses information is really a property of the quantum system as [a] whole, he wrote to IT Business Edge in response to emailed questions. More particles may be needed to define the qubit, but this complexity has an advantage while a local disturbance or perturbation can flip an individual spin, it is much less likely to change the state of the entire quantum system that comprises a topological qubit.Therefore these topological qubits are expected to be more robust.They do not couple well to the commonly occurring noise in the environment.
Preparing for the Quantum Future
There is an angle to all of this that is refreshingly straightforward and accessible, however: Great change is coming and companies need to prepare for quantum computing. Indeed, even assuming that the high-profile changes are down the road a bit, they will be massive when they do arrive.
The bottom line is that planners need to think about quantum computing. A logical first step in assessing the impact is identifying the tasks it will most likely perform. In responses to emailed questions, Jerry Chow, the manager of Experimental Quantum Computing for IBM, told IT Business Edge that four areas likely to be affected are business optimization (in areas such as the supply chain, logistics, modeling financial data and risk analysis); materials and chemistry; artificial intelligence and cloud security.
Things may not be quite as clear cut, however. David Schatsky, the managing director of Deloitte LLP, told IT Business Edge, in response to emailed questions, that risk management, investment portfolio design, trading strategies, and the design of transportation and communications networks will be affected. Quantum computer, he wrote, could be disruptive in cryptography, drug design, energy, nano-engineering and research.
Thats an almost intimidating list. However, Schatsky prefaced it with a disclaimer: Quantum computing will entirely transform some kinds of work and have negligible impact on others. The truth is, researchers dont yet know all the types of problems quantum computing may be good for.
There Is Still Time to Prepare
Luckily, planners have time. Quantum computing will be a massive change, but one that will be gradual. It makes sense to think of quantum computing as a new segment of the supercomputer market, which is a small fraction of overall IT spending, Schatsky wrote. Annual supercomputer server sales total about $11 billion globally by some estimates. I suspect quantum computing revenues will be a very small fraction of that for years to come. So Im not sure its going to become common anytime soon.
Though it clearly will be quite a while before people are buying quantum computers on Amazon, organizations need to be thinking about quantum computing today. The power of quantum computing is so extreme, especially when coupled with artificial intelligence and other emerging techniques, it is clear that all of that time must be put to good use.
IBMs Chow said that quantum-driven platforms such as Watson will be able to find patterns that are buried too deeply for classical computers. This will open new frontiers for discovery, he wrote.
It is a new age, not a new computer.
Corporations should ask: How do I learn about quantum computing to get a feel for where it might make a difference? Now is the time to realize its enormous potential, and that this is a field ripe for innovation and exploration that goes beyond simply just an end application. Becoming quantum-ready is about participating in a revolution within computing. People need to learn the details enough to open their minds up about what could be possible.
And, eventually, quantum mechanics may go beyond computing.
In general terms, I believe the development of quantum technologies is inevitable quantum computing is perhaps just the most visible example, Manfra wrote. It is not hard to imagine that certain businesses in which innovation may be enhanced by dramatic improvement in computational capabilities will need to have long-term plans which exploit quantum machines once they become available.
Carl Weinschenk covers telecom for IT Business Edge. He writes about wireless technology, disaster recovery/business continuity, cellular services, the Internet of Things, machine-to-machine communications and other emerging technologies and platforms. He also covers net neutrality and related regulatory issues. Weinschenk has written about the phone companies, cable operators and related companies for decades and is senior editor of Broadband Technology Report. He can be reached at cweinsch@optonline.net and via twitter at @DailyMusicBrk.
See the original post here:
Are Enterprises Ready to Take a Quantum Leap? - IT Business Edge
Donald Trump justified his decision to withdraw from the Paris climate deal by claiming that compliance would impose crippling economic burdens on the US. I happen to love the coal miners, Trump declared, before reaffirming his intention to make the fossil fuel the centrepiece of the nations energy policy.
The backlash against the president was ferocious, but mainly focused on his lack of concern for the catastrophic effects of climate change. Far less attention has been directed at his conviction that coal will be cheaper than renewable sources of energy in the foreseeable future.
This is a question, luckily, that history can help answer. Recent research suggests that certain technologies introduced over the past two centuries exhibit very predictable rates of advancement, becoming more efficientand thus cheaperat a steady clip. And solar energy is one of those technologies. Looking into the past can give us a glimpse of the future.
In 1965, Gordon Moore, one of the founders of chip giant Intel, noticed that the number of transistors per integrated circuit doubled every two years on average, with corresponding advances in speed and declines in cost. This quickly became known as Moores Law. In the succeeding half century, Moores Law has held up, with the cost of computing power plunging dramatically over the years.
Last year, two economists named J. Doyne Farmer and Francois Lafond published an intriguing paper that riffed off Moores Law. Many technologies, they correctly observed, followed a generalized version of Moores Law in which costs tend to drop exponentially. Some technologies, however, do not follow this model, and it can be hard to distinguish between them. Past performance, in other words, is not always predictive of future results.
In order to sort out the ones that follow a version of Moores Law from the ones that dont, the researchers engaged in an interesting thought experiment. They selected 53 very different technologies across a range of sectors and built a deep database of historical unit costs for producing milk; sequencing DNA; making laser diodes, formaldehyde, acrylic fibre, transistors, and many other things; and electricity from nuclear, coal, and solar.
They then engaged in a statistical method called hindcasting. This entails going back to various points in the past for each technology, taking whatever trend existed at the time and then extrapolating it into the future. They then took this prediction and compared it to what actually happened. This has the virtue of actually testing the predictive power of the data rather than fitting the data to a model. Moreover, it gives some insights into the accuracy of future forecasts. After all, the authors note, a sceptic who looks at the trends in the cost of solar and coal would rightfully respond, how do we know that the historical trend will continue? Isnt it possible that things will reverse, and over the next 20 years coal will drop dramatically in price and solar will go back up? Hindcasting offers a way to answer that question in quantitative terms.
And the answers are rather interesting. The researchers found that many technologies dont follow a robust version of Moores Law, even if the cost per unit can fluctuate a great deal in the short term. The cost of chemicals, household goods, and many other goods dont stay the same, but they fluctuate in a random fashion, going up for a number of years and then going back down again. Others, like transistors and DNA sequencing, are eerily predictable.
Energy, on the other hand, is a mixed bag. The current unit cost of coal is approximately the same as it was in the year 1890 in inflation-adjusted terms. It has, however, fluctuated randomly over time by a factor of three, exhibiting short-term trends that eventually reverse themselves. The same is true of gas and oil. Nuclear has also fluctuated, but is actually more expensive now than when it was first introduced in the 1950s. In short, theres no equivalent for Moores Law when it comes to fossil fuels and nuclear power.
Which brings us to solar. Here the trend has been unmistakable, with the price per unit dropping a very steady 10% per year. This has been a very rapid decline with little variability. Despite changes in demand, the ebb and flow of government subsidies, solar has steadily dropped in cost.
This very Moore-ish trajectory permits us to make reasonably secure predictions about the future cost of solar power. Theres a very slim chance those predictions could be wrong, but compared to predicting the cost of coalwhich is akin to spinning a roulette wheelwe can get some glimpse of the future.
And that future will almost certainly be dominated by solarnot because its green, but because its cheap. Indeed, the authors data suggests that theres a fifty-fifty chance that solar will become competitive with coal as early as 2024; theres a good chance that could happen even sooner. Indeed, it already has in some countries.
In the near future, it will likely be the coal industry that will need subsidies to compete with solar, not the other way around.
Trump can love coal miners all he wants. But he cannot stop solar from becoming the cheapest energy source any more than he could have halted the rise of ever cheaper, more powerful computers. Hes going to loseagain. Bloomberg
Stephen Mihm is an associate professor of history at the University of Georgia
Comments are welcome at theirview@livemint.com
First Published: Tue, Jun 13 2017. 12 14 AM IST
Excerpt from:
Donald Trump's coal bet faces Moore's Law - Livemint - Livemint
Researchers at the National Institutes of Health's National Center for Advancing Translational Sciences and the University of Nevada, Reno School of Medicine have demonstrated that a drug originally targeted unsuccessfully to treat cancer may have new life as a potential treatment for Duchenne muscular dystrophy.
The candidate drug, SU9516, represents a different kind of approach for treating DMD, a degenerative muscle disease that usually begins in childhood and has no known cure. It is caused by a faulty gene that leads to progressive muscle weakness, with death often occurring around age 25. Rather than trying to fix or replace the broken gene, SU9516 ramps up the muscle repair process, helping reinforce muscle structure.
NCATS Chemical Genomics Center Acting Branch Chief Juan Marugan, Ph.D., and UNR Med Professor of Pharmacology Dean Burkin, Ph.D., led a team that screened more than 350,000 compounds to find SU9516, which had been previously developed as a treatment for leukemia. The research demonstrated that this compound improved muscle function in both laboratory and animal DMD models. The results, published recently in Molecular Therapy, may provide a promising approach against the disorder and other muscle-wasting conditions.
{{RelatedArticles}}
Those with DMD lack dystrophin, a protein akin to a molecular shock-absorber that helps keep muscle cells intact. Without dystrophin, muscles are fragile and easily injured. Individuals lose muscle strength and the ability to repair damaged muscle tissue. Most die from heart or respiratory problems.
"Our findings open the door to develop new drug treatments for DMD," Marugan said.
In earlier research, Burkin, who is senior author of the current study, and his co-workers showed that boosting the levels of a cell structural protein, 71 integrin, in affected muscle cells could alleviate DMD symptoms in a mouse model. In addition, increased amounts of the protein slowed the disease's progress.
Burkin and his UNR Med colleagues collaborated with NCATS researchers, including co-team leaders Marc Ferrer, Ph.D., and Noel Southall, Ph.D., to screen a large collection of compounds for molecules that could increase 71 integrin production in mouse muscle cells grown in the laboratory. The screen revealed that SU9516 raised integrin production and promoted the formation of muscle cells and fibers from DMD muscle stem cells, another important indication of its potential as a drug.
In a series of pre-clinical experiments, the researchers showed that SU9516 increased the production of 71 integrin in human and mouse DMD muscle cells. Subsequent tests found SU9516 improved muscle function and slowed indicators of disease progression. Apurva Sarathy, a Mick Hitchcock Scholar, was the lead author on these earlier, published findings, completed as part of her PhD thesis at UNR Med.
{{RelatedDegrees}}
Burkin suggests that such a drug could be used alone, or in combination, with other therapies yet to be developed. There might be wide ranging applications to other muscle-damaging conditions, like cachexia, a wasting syndrome characterized by weight loss and muscle atrophy that is often seen in the late stages of cancers, and the effects of aging and injury, he noted.
"Integrin stabilizes muscle structure, and helps stimulate muscle repair and regeneration," Burkin said. "If we can artificially increase its production with drugs, we think it can help protect muscle cells from damage."
The NCATS-UNR Med team plans to work with medicinal chemists to make the molecule more specific for DMD, while also removing the toxic anticancer components, creating a safer version with a goal of future testing in patients.
The work was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases grants, Cure CMD and Struggle Against Muscular Dystrophy. Other co-authors on the Molecular Therapy article include: Apurva Sarathy, Ryan Wuebbles, Tatiana Fontelonga, Ashley Tarchione, Andreia Nunes, Suzann Duan, Paul Brewer, Tyler Van Ry, Dante Heredia, Grant Hennig and Thomas Gould with UNR Med; and Leslie Mathews Griner, Andres Dulcey, Amy Wang, Xin Xu, Catherine Chen, Xin Hu and Wei Zheng with NCATS.
This story was written by Steven Benowitz, science writer with the National Center for Advancing Translational Sciences, National Institutes of Health.
Shown in the photo are (l-r) Dean Burkin; Pamela Barraza, graduate student; Marisela Dagda, lab manager; Brennan Jordan, undergraduate assistant; Vivian Cruz, lab assistant; Tyler Allen, chief intern; Tatiana Fontelonga, graduate student; and Ryan Wuebbles, research assistant professor.
Link:
Boston Business Journal | GE Healthcare's new CEO has been leading Mass.-based division Boston Business Journal He has overseen significant revenue growth of the molecular medicine business which now accounts for more than $4 billion in sales. Now, Murphy will be tapped to lead the $20 billion GE Healthcare, which is responsible for manufacturing medical ... Kieran Murphy appointed as president and CEO of GE Healthcare 5 things to know about GE Healthcare's new CEO, Kieran Murphy |
View original post here:
GE Healthcare's new CEO has been leading Mass.-based division - Boston Business Journal
New Delhi: Before the ICC Champions Trophy began on June 1, if anyone would have been asked to pick 4 semifinalists, Australia would have surely made the cut never mind judging their credibility of making it to the finals or winning it.
Following a couple of rain-hit encounters and poor overall performance, Australia sought a premature departure from the Mini World Cup, leaving most of the cricketing fraternity in shock.
Shane Warne and Sourav Ganguly, who both have been giving their expert analysis as commentators and pundits for the Champions Trophy, had placed a bet on the outcome of the England Australia match, with Warne, obviously backing the team from Down Under to come out victorious. Ganguly, on the other hand, picked England as the winners.
Here's the full conversation about the bet between Ganguly and Warne:
Ganguly: England is a very good side. They have a number of match-winners in their side. They have good side, better than Australia, I firmly believe.
Warne: You think England are better than Australia. You buying me dinner if Australia win on June 10 and it won't be McDonald's.
Ganguly: I actually back England to win.
Warne: That's what I am saying, I'll buy you dinner if England win.
Ganguly: Fair enough.
Warne: One more thing. If Australia win, you will wear an Australia shirt for day and if England win, I'll wear an England shirt.
Ganguly: No problem.
".@SGanguly99 You win our bet mate. I will find an England shirt and wear it all day," Warne tweeted confirming he had lost the bet.
".@SGanguly99 Trying to get an England ODI shirt sent to me so I can wear it in honour of our bet. Will tweet a picture asap !," the legendary leg-spinner confirmed that he'll be soon tweeting a picture wearing and Engalnd ODI shirt.
Don't know about you but we surely can't wait to see Warne wearing the blues of England!
The Steve Smith-led Aussies went head-to-head against England in the final Group A fixture on Saturday, hoping to end the hosts' unbeaten run in the competition and cement a spot in the last 4.
Courtesy a terrific partnership from centurion Ben Stokes and skipper Eoin Morgan, England secured a 40-run victory (D/L) after rain restricted their innings to 40 overs.
Go here to read the rest:
By Chris Heaney | Staff Writer | 18 hours ago Image by file photo | The Auburn Plainsman
Tuesday, March 28, 2017, in Auburn, Ala.
For many incoming students, getting a part-time job is the last thing on their mind when having to move to a new place, meet new people and start new classes in a totally new environment.
While starting college is definitely a challenge, what many new students dont realize is that having a part-time job or internship can be just as important as a good GPA when applying for jobs in the future.
Addye Buckley-Burnell, assistant director of career development at the Career Center, said work experience is crucial in todays job market.
80-90 percent of employers are telling us that having actual work experience is useful to students when applying for positions, and students with experience are seen more favorably by employers, Burnell said.
Burnell said the first step to finding a job is joining Handshake. Handshake is a job-posting site where employers express employment needs and all kinds of time commitments.
Registered students will automatically be added to the system and can log in with their University credentials. Once logged in, Burnell said to optimize ones profile.
We encourage students to have [their page] as updated as possible, Burnell said. They can essentially upload a resume and click add to profile which will include all the elements of their resume fully.
Burnell said the system works best when used frequently. The success rate in finding a position using this system is very high for students, Burnell said.
Helping to find a job during college isnt the only service that the Career Center provides, though.
Its for everything career related, from the day they first walk on campus to five years after theyve graduated, Burnell said.
Students who visit the Career Center will be able to utilize services like career assessments, interview preparation, resume and CV reviews and professional development discussions. The Career Center is open to all students of any major, and students can have walk-in appointments during business hours, Monday-Friday.
For students eager to get a job when the fall semester starts, the Career Center will be holding an internship and part-time job fair on Aug. 30.
It will feature employers from the Auburn area who are going to be hiring in the fall. The event is free to all students.
Its a great way for students to get connected with positions they may not know about, Burnell said.
Excerpt from:
Making crucial connections while making bank: Advice from the Career Center - The Auburn Plainsman
The supposed last day of registrations to Delhi University's undergraduate saw students running helter-skelter to help desks and online centres to get assistance on completing the form and other formalities.
There are students whose Class XII results are yet to be declared, which includes students of the International Baccaulaureate (IB) Board and a few other boards.
Keeping the concerns of students in mind, the University decided to extend the deadline till Tuesday 5pm.
However, several students such as those of Uttar Pradesh board, especially in places where results have been declared late are helpless due to the deadline and the late result may cause them to lose their chance to register. Many students have faced issues in the past on the admissions portals, and the University has regularly assured and resolved such problems within two-three days.
There are, however, students who continue to have troubles with payment of fees. Some have even paid the fee twice just to make sure the registration is complete and a receipt is generated.
Mukul Sehrawat, a Statistics Honours aspirant, said: "I have given an application to the help desk to check whether or not my fee has been paid. I am really worried."
Neha Sharma, another applicant, said: "Fee receipt has been a major issue and I wish the University can give us a guarantee that it will be generated soon, given that portal is going to be closed soon and cut-offs are just a week away."
Nishika Khanna, who has applied for English Honours, said: "I have paid the fees twice and wonder whether the receipt has been generated."
Some have faced logistical problems, due to internet connectivity problems or lack of computing knowledge in uploading documents and paying fees online.
Satvik Kumar, a BCom aspirant, said: "Last date of admission registration is about to end and I am unable to upload my marksheet. I am going to Hansraj College where an online centre is helping students."
Dia Shekhawat, another aspirant, said: "I am from Uttar Pradesh board and my marksheet has not come yet. Therefore, DU must extend the deadline."
Gunjan Kaur, a History aspirant, said: "I don't know how to do credit or debit card payment and will ask someone to help me. DU can extend the deadline for other state boards I think."
Meanwhile, reacting to the report by Millennium Post on June 6 which talked about 'Gurukul-style' training lessons to be introduced in Ramjas College for freshers for the current admission process, the College authorities have said that the report is not official college policy as of now, and the views expressed are solely of Professor Dhani Ram, who was quoted in the story.
See the original post here:
Late Class XII result, online payment issues stifling UG registrations - Millennium Post
Share your photos and keep up to date with the photo activity of your friends from your Android device
Read More: Android Flickr geotag images photos sharing
Software Publisher
Our Rating: 4.0
Introducing the new Flickr app upload, access, organize, edit, and share your photos from any device, from anywhere in the world.
Put your free 1000GB to work auto-upload all your photos and videos, privately storing them in your Flickr camera roll. Camera roll in the cloud instant access to your entire Flickr collection, so you can free up your phone for everything else. Organization and sharing, simplified browse with ease, select and organize hundreds of photos with one gesture, and share in seconds. Unleash your creativity tweak your photos, add filters, crop images and more, directly from the camera roll. And if you change your mind, just revert the changes! Explore, interact and engage with friends, family and the Flickr community there are millions of groups and billions of photos out there to discover.
Whats New We cant spill the beans, Exciting updates ahead; But first some tidbits! Add photos to multiple groups at the same time. Add tags to other photos. Further performance and usability enhancements.
Read More: Android Flickr geotag images photos sharing
Published by Mediateam Ltd., Ireland technology media leader since 1976, 55 Spruce Ave, Sandyford, Dublin 18, A94 N125.
See more here:
About 8,000 UnitedHealthcare customers who get care from University of Chicago Medicine might have to switch doctors this summer or pay significantly more for services because of a contract disagreement between the insurer and the medical system.
UnitedHealthcare the state's second-largest health insurer and University of Chicago Medicine have been unable to agree on a contract to keep the medical center and the system's doctors in the insurer's network.
Both sides say in statements on their websites that they're still negotiating. But they're also warning that patients may no longer be able to get in-network care at the University of Chicago Medical Center or from University of Chicago Physicians Group after June 30 if no agreement is reached.
U. of C. Medicine sent letters to patients last week saying that UnitedHealthcare is ending its contract with the academic medical center and its physicians group after June 30. Patients with preferred provider organization and point-of-service plans would have to pay out-of-network rates, according to UnitedHealthcare.
The U. of C. Medicine letter, however, says that UnitedHealthcare members undergoing "active treatment" might be able to continue getting care at in-network rates for a time. That may include people who are already in the hospital, many pregnant women, nonsurgical cancer patients, patients with end-stage renal disease, dialysis patients and symptomatic AIDS patients, according to the letter. Patients have to contact UnitedHealthcare to see if they qualify.
UnitedHealthcare customers in group retiree Medicare Advantage plans and Medicare Supplement plans will not be affected by the contract negotiations, according to UnitedHealthcare.
Representatives of UnitedHealthcare and U. of C. Medicine declined to discuss details of the disagreement.
But the insurer said in a statement that it remains "committed to working with University of Chicago officials on a new contract."
"We recognize the important role University of Chicago plays in supporting the health care needs of our members, and our two organizations have met regularly over the last few months to reach a solution that will renew our relationship," UnitedHealthcare said.
In an email, U. of C. Medicine spokeswoman Ashley Heher said, "The medical center is committed to making sure its care and expertise is available to as many people as possible, including about 8,000 UChicago Medicine patients who are currently covered by UnitedHealthcare's commercial insurance plans."
The uncertainty is sparking stress among patients.
Ivy Elkins, of Buffalo Grove, has been seeing her University of Chicago Medicine oncologist since she was diagnosed with stage 4 lung cancer more than three years ago. Elkins, 50, researched and carefully selected her doctor, and followed her to the University of Chicago from a different hospital system.
She's unsure if she'll qualify, as a cancer patient, to continue receiving care if the contract falls through.
"As a level 4 cancer patient, you build up this level of trust, and I trust her," Elkins said. "Every decision she's made for my health up to this point has been spot on, and I don't want that to change in any way."
Twitter @lschencker
Read more here:
University of Chicago Medicine may soon be out of UnitedHealthcare's network - Chicago Tribune
BOSTON In 1989, when he was a 19-years-old college student, Eric Dishman was diagnosed with a rare kidney cancer and given just months to live.
Instead he spent the next 23 years visting 17 hospitals and clinics across eight states, receiving exhaustive and exhausting treatment more than 60 rounds of chemotherapy, radiation and/or immunotherapy than ended up costing more than $6 million.
Over the decades, he received 57 different diagnosis codes. Even in the early days, he remembers "two oncologists arguing in front of me about what I really had," said Dishman, keynoting the HIMSS Precision Medicine Summit in Boston on Monday.
[Also:Widespread precision medicine is still years away, experts say]
By the time he was in his early 40s, the prognosis was not good. His kidneys were failing, and dialysis was not compatible with the chemotherapy he needed.
At that time, Dishman was a fellow at Intel; in what he described as a "Hail Mary" gambit, one of his colleagues suggested he avail himself of the company's technology and undergo a whole-genome sequencing.
The insights gleaned from the three terabytes of genomic data that resulted changed everything. Clinicians suddenly realized that his unique form of cancer has more in common with pancreatic disease than with renal cancer, said Dishman.
[Also:How precision medicine can fix a broken healthcare system]
That enabled them to better target their treatment plan, and before long he was cancer free and eligible for a kidney transplant.
Dishman's doctor eventually told him that 90 percent of the treatment regimens he'd endured for more than than 20 years millions of dollars worth of "imprecision medicine" had been essentially worthless.
In 2016, President Barack Obama asked Dishman to head up the cohort program of the landmark Precision Medicine Initiative.
Now, as the director of what's become known as the All of Us Research Program at the National Institutes of Health, Dishman said he aims to make that patient cohort as large and representative of the U.S. population as possible.
He's also keenly aware, he said, of how lucky he was to receive the treatment he did and how great it wouldbe to democratize it. Even a a high-powered technology executive, with a smartphone filled with the names of senators and CEOs, "I barely got access to precision medicine," said Dishman. "So how do we scale that to everybody?"
Dishman has done advocacy for more than 1,100 cancer and kidney patients, and he's donated his whole-genome data to a survivor study to learn what other insights might be gleaned from it. But he wants more.
And that starts with casting as wide a net as possible for the million participants he hopes to sign up for the NIH All of Us program to speed precision medicine advances.
Most medical research participants are college-educated white men, said Dishman. "We don't have the depth of data to understand what causes illness and health."
By accounting for big individual differences in lifestyle, environment and genetics, NIH researchers will better be able to uncover new strategies for delivering precision medicine to more people he said.
Right now, healthcare is primarily delivered in an expensive "medical mainframe," said Dishman, using a computing analogy, with the focus on expensive and resource-intensive specialty hospitals, emergency rooms and ICUs.
The path forward has to be away from the "medical megaplex with the high priests of healthcare," and toward a more "personal, distributed" healthcare and health research that embraces telehealth, remote monitoring, wearables, home physician visits and more.
Rather than remaining only the province of large academic medical centers, Dishman sees a day in the not-too-distant future where genomic data could, for instance, be collected at the drugstore or even at the workplace.
But between now and then, there are four challenges but also opportunities to arriving at that model for personal, distributed research:
Toward that end, the All of Us project has three big goals, said Dishman: first, to nurture relationships with one million U.S. trial participants, "from all walks of life," for decades to come. Second, to deliver the "largest, richest biomedical dataset" yet compiled, and making it easy, safe and free to access. Third, to to catalyze a robust ecosystem of diverse researchers and funders, hungry to use and support it.
It won't be easy, but by distributing data collection and diversifying to that large and broadly diverse group, engaging them on a longitudinal basis (perhaps as long as 60 years), NIH will help democratize its research to a wider continuum of expertise, said Dishman approaching a "universal cohort" and something akin to a "learning healthcare system."
Twitter:@MikeMiliardHITN Email the writer: mike.miliard@himssmedia.com
Like Healthcare IT News on Facebook and LinkedIn
Go here to read the rest:
Eric Dishman wants precision medicine to move from personal to universal - Healthcare IT News
While the Office of the National Coordinator believes the dawn of precision medicine has started, when pressed on the current state of the innovative technology, technology leaders say that the industry is still years away from full utilization.
In fact, on a scale of one to 10, most would place precision medicine at a three in terms of progress.
The landscape is changing so quickly and things [in the industry] have changed so much already, University Of California, San Francisco Director of Research Strategy and Associate Director of Precision Medicine India Hook-Barnard said at the HIMSS Precision Medicine Summit in Boston on Monday.
[Also:How precision medicine can fix a broken healthcare system]
Thats not to diminish the progress thats already happened, but I also think theres so much thats going to be happening moving forward, she said.
Pegasystems Director of Industry Principal Amy Simpson said there are tremendous accelerators like cost reductions that are helping make the shift to fully utilizing the technology. But real operational efforts are what will really fuel the precision medicine push.
To Stanford University Chief of General Primary Care Megan Mahoney, when considering how far along the industry is, its important to view it by function. While building big data is pretty advanced, genomics is still in the early stages.
[Also:Eric Dishman wants precision medicine to move from personal to universal]
We have to recognize that only 1 percent of patients have access to [precision medicine],said National Institutes Of Health All Of Us Research Program Director Eric Dishman. Success plus results minus expectations Were still about 15 to 20 years out.
The challenges to precision medicine are the same as the other issues facing the healthcare industry, said Simpson. Effective EHR implementation and the shift to value based care are going to pose the same problem to implementing precision medicine.
Providers really need to think about patient support. Simpson said that so much of the patient engagement framework and saturation will be critical to keeping patients engaged throughout the life cycle.
The realistic solution to some of these issues is the coordination, said Hook-Barnard. Its going to be about partnerships across multiple disciplines It really is the regulatory, policy and cultural changes that are slowing us down.
Organizations need to coordinate and forge those partnerships, which Hook-Barnard feels is one of the biggest challenges.
The revolution Mahoney sees will come with actively engaging our data and effectively bringing patients along, which will reduce costs.
Twitter:@JessieFDavis Email the writer: jessica.davis@himssmedia.com
Like Healthcare IT News on Facebook and LinkedIn
See the rest here:
Widespread precision medicine is still years away, experts say ... - Healthcare IT News
June 12, 2017
Traditional Chinese medicine might be effective as a complement or alternative to traditional Western medicine for primary and secondary prevention of heart disease, according to a state of the art review paper published today in the Journal of the American College of Cardiology.
Heart disease is the No. 1 cause of death worldwide, and despite advances in Western medicine for treating and preventing heart disease, unmet needs remain. As a result, traditional Chinese medicine is being increasingly looked at as a supplement to Western medicine, but to date randomized controlled trials are overall of poor quality and flawed.
Western scientists often reject Chinese medicine for specific reasons: the formula consists of dozens of ingredients with many chemical molecules, making it hard to clarify the therapeutic mechanism; the medications available in China do not undergo the same rigorous approval process as Western drugs to guarantee efficacy and safety; and most trials were conducted in China by traditional Chinese medicine physicians with medications largely unavailable in the United States.
Researchers in this review looked at studies published over the past 10 years on randomized controlled trials of traditional Chinese medicine used for patients with hypertension, dyslipidemia, diabetes/pre-diabetes, atherosclerotic cardiovascular disease and chronic heart failure to assess the efficacy and safety of traditional Chinese medicine.
In all, certain Chinese medications showed suggested benefits for each of the cardiovascular health conditions studied. For example, researchers looked at eight randomized controlled trials on traditional Chinese medicine and hypertension. The evidence indicated that Tiankuijiangya, Zhongfujiangya, Qiqilian, Jiangya and Jiangyabao have antihypertensive effects and a good safety profile, making them a potential good alternative for patient intolerant of or who cannot afford Western medications.However, whether those benefits transferred into long-term positive cardiovascular outcomes would have to be determined by long-term trials.
"Of note, one should bear in mind that traditional Chinese medicine medications are usually prescribed as complex formulae, which are often further manipulated by the practitioner on a personalized basis," said Yuxia Zhao, senior author of the review and a physician in the Department of Traditional Chinese Medicine at Shandong University Qilu Hospital in Jinan, Shandong, China. "The pharmacological effects and the underlying mechanisms of some active ingredients of traditional Chinese medications have been elucidated. Thus, some medications might be used as a complementary and alternative approach for primary and secondary prevention of cardiovascular disease."
Explore further: Can traditional chinese medicine offer treatments for dementia and Alzheimer's disease?
A new study of classical Chinese medical texts identifies references to age-related memory impairment similar to modern-day Alzheimer's disease, and to several plant-based ingredients used centuries agoand still in use ...
Traditional Chinese exercises such as Tai Chi may improve the health and well-being of those living with heart disease, high blood pressure or stroke, according to new research published in the Journal of the American Heart ...
Researchers at the University of Adelaide have shown how a complex mix of plant compounds derived from ancient clinical practice in China a traditional Chinese medicine works to kill cancer cells.
China will double the number of AIDS patients it treats with traditional Chinese medicine (TCM), officials have said, part of a broader push to increase the use of the ancient practice in the country's medical system.
Physicians should be well-versed in the herbal medications heart disease patients may take to be able to effectively discuss their clinical implications, potential benefits and side effectsdespite a lack of scientific ...
(Medical Xpress)Traditional Chinese medicine could be a key weapon in the treatment of type 2 diabetes, a joint international study has found.
A new study shows that a hybrid molecular imaging system unites three imaging modalities to map the composition of dangerous arterial plaques before they rupture and induce a major cardiac event. The research was presented ...
A study by the University of Birmingham has revealed a treatment gap in patients suffering from a heart condition that causes an irregular or abnormally fast heartbeat.
Researchers have long sought ways to harness the body's immune system to treat disease, especially cancer. Now, scientists have found that the immune system may be triggered to treat atherosclerosis and possibly other metabolic ...
Seventy per cent of readings from home blood pressure monitors are unacceptably inaccurate, which could cause serious implications for people who rely on them to make informed health decisions, new UAlberta research reveals.
(HealthDay)Adoption of four healthy lifestyle behaviors is associated with increased lifespan for men and women, according to a study published online May 31 in the Journal of Internal Medicine.
Heart disease remains the leading cause of death worldwide, yet the few available treatments are still mostly unsuccessful once the heart tissue has suffered damage. Mammalian hearts are actually able to regenerate and repair ...
Adjust slider to filter visible comments by rank
Display comments: newest first
I thought it was because I gave up soft drinks and was only drinking water. One day I had a stomachache. I was in bed for 4 days. The doctor's appointment was for a Wednesday. I got sick and went to emergency room on a Monday. I was told my blood sugar level was 810 and I have diabetes. Since then, I eat better, take better care of myself and went from 260 to 220 lbs.and was thirsty all the time. One day I got extremely sick, could not keep anything down, had blurry vision, a rapid heartbeat, and began hyperventilating. taking metformin 1000 mg twice daily. I am writing this to inform others that nothing was really working to help my condition.I went off the metformin (with the doctor's knowledge) and started on Diabetes herbal formula i ordered from Health Herbal Clinic, my symptoms totally declined over a 5 weeks use of the Diabetes natural herbal formula. i am now doing very well, Visit there website www. healthherbalclinic. net or email Info@ healthherbalclinic. net
Please sign in to add a comment. Registration is free, and takes less than a minute. Read more
Read more:
Traditional Chinese medicine may benefit some heart disease patients - Medical Xpress